GRFS (Grifols, S.A.) Forward P/E Multiple
This daily chart from GURU.Markets, illustrating the forward P/E multiple of Grifols, S.A. (GRFS), demonstrates stable cash flow and liquidity, while the 7.20 level represents the current value. Dominance in the plasma segment and debt reduction are driving growth. The business's low cyclicality is guaranteed by steady demand for immunoglobulins, which remains virtually independent of economic crises.
Analytical breakdowns for Grifols, S.A.
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
GRFS - Final Profit|Projected Future Earnings Grifols, S.A.|GRFS - Business Payback Period|Forward P/E Multiple Grifols Group|GRFS - Market Cap to Earnings and Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Grifols SA|GRFS - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Grifols|GRFS - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months grifols.com|GRFS - Expected net earnings per share growth this year|Expected earnings per share growth for next year Grifols, S.A.
- total revenue and sales volume data:
Summary company analytics:Grifols
To isolate the fundamental stability of Grifols, S.A. (GRFS) from market noise, a calculation of the company's expected price-to-earnings ratio is used, weighing market expectations against the risks of a trend reversal. A surge in this metric signals overvaluation, while a drop toward lows warns of capital freezing in an asset whose reliability is confirmed by a complex cold chain system for the transportation of plasma products.
Competitors of Grifols, S.A. (GRFS)
Projected Price to Earnings ARGX (argenx)|BNTX (BioNTech Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (abivax.com)|Market Cap to Projected Earnings ADMA Corp (ADMA)|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|Kiniksa (KNSA) - Future Price to Earnings|Projected Price to Earnings Adaptive Biotech|Projected Price to Earnings CLDX|Forward P/E Multiple Aurinia Corp|Future Price to Earnings BioCryst (BCRX)|veratx.com - Price to Future Earnings Ratio|Forward P/E Multiple DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Projected Price to Earnings Ratio|AbCellera Bio - Forward P/E Multiple|Forward Price to Earnings Multiple Tourmaline (TRML)|Precigen, Inc. (PGEN) - Future Price to Earnings|pharming.com - Future Price to Earnings Multiple|NKTR (Nektar Therapeutics Inc.) - Forward P/E Multiple|Upstream Bio, Inc. (UPB) - Market Cap to Projected Earnings|Forward P/E Multiple ZBIO|IMNM: Price to Expected Earnings Ratio|Future Price to Earnings Gossamer Bio, Inc. GOSS|kalvista.com (KALV) - Projected Price to Earnings Ratio|SEPN - Future Price to Earnings|PVLA: Future Price to Earnings|Savara Corp (SVRA) - Future Price to Earnings|RIGL - Market Cap to Projected Earnings|Projected Price to Earnings ANAB|ATXS: Future Price to Earnings Multiple|Future Price to Earnings enGene (ENGN)|Market Cap to Projected Earnings RAPT Therapeutics Inc.|Aerovate Therapeutics - Projected Price to Earnings|Market Cap to Projected Earnings Aclaris Therapeutics, Inc (ACRS)|Kyverna Therapeutics - Forward P/E Multiple|TLSA - Forward P/E Multiple|CABA (Cabaletta Bio) - Projected Price to Earnings|VTYX - Market Cap to Projected Earnings|THTX (Theratechnologies Inc) - Forward P/E Multiple|AVTX - Forward Price to Earnings Multiple|Future Price to Earnings Eledon Pharmaceuticals (ELDN)|AGEN (agenusbio.com) - Future Price to Earnings Multiple|Forward P/E Multiple CLYM (Climb Bio)|ZURA (Zura Bio Ltd) - Price to Expected Earnings Ratio|ATYR - Future Price to Earnings|Market Cap to Projected Earnings Adagene ADAG|ikenaoncology.com (IMA) - Future Price to Earnings|Price to Expected Earnings Ratio STTK (Shattuck Labs)|EQ (Equillium Inc) - Forward P/E Multiple|CNTB: Future Price to Earnings Multiple|Forward P/E Multiple IMUX|Forward P/E Multiple atarabio.com (ATRA)|Future Price to Earnings InflaRx IFRX|Future Price to Earnings Multiple XFOR|ACET - Future Price to Earnings|Celularity Inc. (CELU) - Projected Price to Earnings|INMB: Forward P/E Multiple|Barinthus Biotherapeutics Corp (BRNS) - Forward P/E Multiple|Projected Price to Earnings KZR|SABS: Future Price to Earnings Multiple|Forward P/E Multiple AKTX|Market Cap to Projected Earnings enlivex.com|Future Price to Earnings Q32 Bio QTTB|GOVX - Projected Price to Earnings|EDSA - Future Price to Earnings|ibioinc.com (IBIO) - Projected Price to Earnings|CARM (carismatx.com) - Projected Price to Earnings|XTL Biopharmaceuticals Ltd (XTLB) - Forward P/E Multiple|Future Price to Earnings Bolt Biotherapeutics Inc.|Price to Future Earnings Ratio HCWB (HCW Biologics Inc)|Forward P/E Multiple APVO|AIM - Projected Price to Earnings Ratio|Forward P/E Multiple ADTX (Aditxt, Inc.)|Forward Price to Earnings Multiple GRI Bio Inc|XRTX - Future Price to Earnings|Future Price to Earnings Multiple HIND (Vyome Therapeutics)|REVB: Forward P/E Multiple|INDP - Market Cap to Projected Earnings|SCNI (Scinai Immunotherapeutics Ltd.) - Forward P/E Multiple|CalciMedica Corp - Price to Expected Earnings Ratio|Future Price to Earnings Affimed (AFMD)|ALLK - Projected Price to Earnings Ratio|Future Price to Earnings HOOKIPA Pharma HOOK|IGM Biosciences Inc. - Future Price to Earnings|ITOS - Future Price to Earnings|Market Cap to Projected Earnings Ocean Biomedical Inc OCEA|TCBP (TC BioPharm (Holdings) PLC) - Projected Price to Earnings|Third Harmonic Bio Inc - Future Price to Earnings Multiple
